The Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy in Acute Myeloid Leukaemia : An IndividualPatient Data Meta-analysis of Randomised Trials in Adults

BACKGROUND: Gemtuzumab Ozogamicin (GO) was the first example of antibody directed chemotherapy in cancer and developed for Acute Myeloid Leukaemia. Its role has been unclear. Five randomised trials where it was combined with standard induction chemotherapy in adults have produced different results....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hills, Robert K, Castaigne, Sylvie, Appelbaum, Frederick R, Delaunay, Jacques, Petersdorf, Stephen, Othus, Megan, MD, Elihu H Estey, Dombret, Hervé, Chevret, Sylvie, Ifrah, Norbert, Cahn, Jean-Yves, Récher, Christian, Chilton, Lucy, Moorman, Anthony V, Burnett, Alan K
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137593/
https://ncbi.nlm.nih.gov/pubmed/25008258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70281-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados